DBV Technologies SA

DBV Technologies Announces Results of Its 2022 Ordinary and Extraordinary General Meeting

12 May 2022 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies Completes ADSs Sale of an amount of $15.3 million on Nasdaq through its At-The-Market program (ATM)

04 May 2022 19:30:00 By Nasdaq GlobeNewswire

DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq

02 May 2022 17:00:24 By Nasdaq GlobeNewswire

DBV Technologies Reports Recent Business Developments and First Quarter 2022 Financial Results

02 May 2022 16:00:00 By Nasdaq GlobeNewswire

DBV Technologies to Report First Quarter 2022 Financial Results and Recent Business Developments

25 Apr 2022 16:30:00 By Nasdaq GlobeNewswire

Ordinary and Extraordinary General Meeting of May 12, 2022

21 Apr 2022 16:30:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2022

14 Apr 2022 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Present at the Oppenheimer’s 32nd Annual Healthcare Conference

14 Mar 2022 16:30:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of February 28, 2022

11 Mar 2022 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies Announces Filing of 2021 Annual Report on Form 10-K and 2021 Universal Registration Document

09 Mar 2022 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies Reports Full Year 2021 Financial Results and Recent Business Updates

03 Mar 2022 16:15:00 By Nasdaq GlobeNewswire

DBV Technologies to Report Full Year 2021 Financial Results and Business Updates on March 3, 2022

24 Feb 2022 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Participate in Upcoming AAAAI 2022 Congress

22 Feb 2022 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Present at the 11th Annual SVB Leerink Global Healthcare Conference

14 Feb 2022 16:30:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of January 31, 2022

09 Feb 2022 16:30:00 By Nasdaq GlobeNewswire

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

21 Jan 2022 16:30:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2021

12 Jan 2022 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Present at the H.C. Wainwright BioConnect 2022 Conference

07 Jan 2022 01:30:00 By Nasdaq GlobeNewswire

DBV Technologies Provides Update on Investigational Viaskin™ Peanut

20 Dec 2021 16:15:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2021

10 Dec 2021 16:30:00 By Nasdaq GlobeNewswire